How one of the UK’s brightest startups lost its rights to the Oxford vaccine

  • 📰 The Telegraph
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Vaccitech is about to float for $700m in New York, but its vaccine heroics are a mere footnote in its prospectus for potential investors

At Oxford University, a long history of scientific triumph has often not been matched by commercial success. Its failure to exploit the discovery of antibiotics haunts the dreaming spires, according to Robin Wright, the chairman of the Covid vaccine developer Vaccitech.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 41. in LAW

Law Law Latest News, Law Law Headlines